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Available online 5 September 2012Abstract Neurons resembling the spiral ganglion neurons (SGNs) of the auditory nerve can be generated from embryonic stem cells
through induced overexpression of the transcription factor Neurogenin-1 (Neurog1).While recapitulating this developmental pathway
produces glutamatergic, bipolar neurons reminiscent of SGNs, these neurons are functionally immature, being characterized by a
depolarized resting potential and limited excitability. We explored the effects of two neurotrophins known to be present in the inner
ear, brain derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), on the electrophysiology of neurons following Neurog1
induction. Our data reveal a significant reduction in resting membrane potential (RMP) following neurotrophin exposure, with BDNF
producing amore robust effect thanNT-3. This effectwas accompanied by a profound and specific upregulation of the KCNQ4 subtype,
where a 9-fold increase was observed with quantitative PCR. The other neuronally expressed KCNQ subtypes (2, 3, and 5) exhibited
upregulation which was 3-fold or less in magnitude. Quantitative immunohistochemistry confirmed the increase in KCNQ4 expression
at the protein level. The present data show a novel link between BDNF and KCNQ4 expression, yielding insight into the restricted
expression pattern of a channel known to play special roles in setting the resting potential of auditory cells and in the etiology of
progressive high‐frequency hearing loss.
© 2012 Elsevier B.V. All rights reserved.Introduction
Hearing loss results when the cells of the auditory system are
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damaged cells of the auditory system, including the sensory
receptors (hair cells) and the spiral ganglion neurons (SGNs) that
populate the auditory nerve (Brigande and Heller, 2009;h.edu (A. Yang), leahpeng@umich.edu (L. Liu),
les), rkduncan@umich.edu (R.K. Duncan).
30 E.K. Purcell et al.Glavaski-Joksimovic et al., 2009, 2008; Regala et al., 2005;
Sekiya et al., 2008). O'Shea and colleagues have demonstrated
the differentiation of mouse ESCs into a phenotype resembling
SGNs via doxycycline (dox)‐induced overexpression of the basic
helix-loop-helix transcription factor Neurogenin-1 (Neurog1)
(Altschuler et al., 2008; Reyes et al., 2008; Velkey, 2005).
Neurog1 initiates signaling cascades required for SGN survival
and migration, and overexpression promotes neuronal differen-
tiation while decreasing gliogenesis (Huang et al., 2001; Kim et
al., 2001; Sun et al., 2001). While recapitulating this develop-
mental pathway rapidly produces “SGN-like” neurons, these
neurons have a depolarized resting potential and limited ability
to generate action potentials from rest, indicating functional
immaturity (Magnuson et al., 1995; Reyes et al., 2008; Tong et
al., 2010). Fine-tuning the physiological phenotype of these
stem cell-derived neurons will require additional strategies to
manipulate the expression of the ionic conductances that
govern excitability.
Neurotrophins are known to modulate the electrophysio-
logical function of a variety of sensory neurons, and as such,
they are viable candidates to engineer the electrophysiology
of Neurog-1 induced neurons (Rothe et al., 1999; Youssoufian
and Walmsley, 2007; Zhang et al., 2008). In the cochlea,
opposing gradients of BDNF and NT-3 may underlie the
frequency-dependent tuning of SGNs, where apical SGNs are
exposed to high concentrations of neurotrophin-3 (NT-3) and
basal neurons experience high BDNF exposure (Adamson et al.,
2002a, 2002b; Ruttiger et al., 2007; Zhou et al., 2005). BDNF
and NT-3 have been shown to differentially modulate the
firing features of mature SGNs innervating these spatially
distinct regions of the cochlea (Adamson et al., 2002a, 2002b).
The roles these factors may play in the electrophysiological
maturation of SGNs, however, is unknown.
In this study, we studied the effects of combining an
induced genetic program and extrinsic soluble cues on the
passive electrical properties and KCNQ potassium channel
expression in stem cell-derived neurons. BDNF significantly
reduced the resting membrane potential of these cells. This
result was coupledwith a profound and specific increase in the
expression of a potassium channel subtype known to play a
role in setting the resting potential of auditory cells (KCNQ4)Table 1 Neurotrophin treatment following Dox-induced
neuronal differentiation shifts the resting potential to a
reduced, more physiologic range. BDNF had a more profound
effect on resting potential than NT-3 (pb0.001 level, ANOVA).
Changes in passive properties imply neuronal maturation after
BDNF exposure, where BDNF produced an increase in membrane
capacitance (Cm) and a reduction in input resistance (Rin).
Control
(n=16)
NT-3
(n=17)
BDNF
(n=19)
RMP
(mV)
−37.1±1.5 −41.2±1.1 −50.7±1.1⁎⁎⁎,†
Cm
(pF)
12.4±1.0 14.2±1.1 20.3±1.3⁎⁎,†
Rin
(MΩ)
792±130 541±75 224±21⁎,†
†pb0.001 vs. control; *pb0.05 vs. NT-3; **pb0.01 vs. NT-3,
***pb0.001 vs. NT-3.(Beisel et al., 2000; Kubisch et al., 1999; Oliver et al., 2003).
Intriguingly, this specific channel subtype is expressed in a
‘tonotopic’ gradient in the cochlea (being expressed most
strongly in the high-frequency encoding basal neurons), and
mutations in this gene are known to cause progressive
high-frequency hearing loss (Beisel et al., 2000; Kubisch et
al., 1999). This study yields insight into the potential plasticity
of Neurog1-neurons to locally secreted neurotrophins in a
regeneration application, provides a means of reducing the
abnormally depolarized resting potential of Neurog1-induced
neurons, and demonstrates a novel connection between BDNF
and expression of the KCNQ subtype implicated in progressive
high‐frequency hearing loss.Materials and methods
Cell culture and neurotrophin treatment
A reverse tet-transactivator system was used to force the
expression of Neurog1 in a GFP-expressing mouse embryonic
stem cell line (K9), and the culture of these cells has been
previously described (Reyes et al., 2008). Selection antibi-
otics puromycin (1.5 μg/mL), hygromycin (300 μg/mL) and
G418 (350 μg/mL) were added to maintain cells. For differen-
tiation, cells were dissociated and seeded in serum-free
differentiation medium (80:20 media), which included 80%
F12/DMEM 1:1, 20% Neurobasal, 10 mM sodium pyruvate, 0.8%
N2 supplement, and 0.4% B27 supplement (all from Invitrogen).
Cells were plated on tissue culture treated (Thermanox)
coverslips coated with 0.1% gelatin. Neurog1 expression was
induced with 1 μg/mL doxycycline in 80:20 media for 3 days
with half-volumemedia exchanges each day. After 3 days, cells
were maintained in DMEM with 5% knock-out serum replace-
ment (Invitrogen) and 5% embryonic stem cell supplement
(DMEM with 24% HEPES buffer, 4 mg/mL L-glutamine, and
70 ng/mL beta-mercaptoethanol). Cells then received one of
three treatments for the following 4 days: (1) BDNF, 10 ng/mL,
(2) NT-3, 10 ng/mL, or (3) carrier control (diluted bovine serum
albumin). Media was changed each day with freshly diluted
neurotrophins. Maximal effects of BDNF and NT-3 on SGNs
reportedly occur at a 10 ng/mL concentration (Smith and Davis,
2011; Zhou et al., 2005).Neurotrophin effects on passive properties
RMP was measured using whole-cell current-clamp recordings
(I=0 setting) using an Axopatch 200B amplifier, Digidata 1322A
digitizer, and the pClamp 9.0 software suite (Axon Instru-
ments, Foster City, CA). Sample size for RMP measurement
was between 17 and 20 cells per treatment group. Access
resistance (Ra), membrane capacitance (Cm), and input
resistance (Rin) were measured using the Membrane Test in
pClamp (9–12 cells assessed per treatment group). Microelec-
trodes were pulled from borosilicate glass capillaries (World
Precision Instruments, Sarasota, FL) with a resistance of ~7–
10 MΩ, and access resistances were unaffected by treatment
condition (average: 17.1±0.9 MΩ). A generalized description
of whole‐cell recordings in Neurog1-induced cells and external
and internal solution composition have been detailed previ-
ously (Tong et al., 2010).
31BDNF increases KCNQ4 expression in neurons derived from embryonic stem cellsQuantitative polymerase chain reaction (qPCR)
Cells were seeded at a density of 500,000 cells/well in a
6-well plate, cultured and treated with neurotrophins as
described in the Cell culture and neurotrophin treatment
section. Total RNA was extracted using RNeasy Mini Kit
(Qiagen) according to the manufacturer's instructions at the
7 day time point. Reverse transcription was achieved using
oligo(dT) primers and SuperScript III Reverse Transcriptase
(Invitrogen) according to the manufacturer's instructions.
TaqMan Gene Expression Assays (Applied Biosystems) were
used to conduct qPCR experiments on four biological repeats
for each condition. Thermocycling and data analysis were
performed using an ABI PRISM 7900HT thermocycler and
StepOnePlus analysis software (Applied Biosystems). Cycle
threshold (CT) was determined for the genes of interest:
KCNQ2 (Probe Assay Mm00440080_m1), KCNQ3 (Probe Assay
Mm00548884_m1), KCNQ4 (Probe Assay Mm01185500_m1),
KCNQ5 (Probe Assay Mm01226041_m1), DCC (Probe Assay
Mm01262265_m1) and the housekeeping gene GAPDH (Probe
Assay Mm99999915_g1). Efficiency curves were generated
from serially diluted concentrated cDNA obtained from
induced ESC samples (efficiencies were all N90%). Changes
in gene expression in neurotrophin-treated versus control
cells were assessed using the ΔΔCT method (Li et al., 2009).
Reactions were performed in triplicate. The standard
deviation of triplicate CTs for all probes in all samples fell
below 0.2.Quantitative immunohistochemistry
Cells were seeded at a density of 150,000/well onto gelatin-
coated tissue culture-treated coverslips in a 24-well plate,Figure 1 BDNF profoundly increases KCNQ4 transcription
in Neurog1-induced neurons. BDNF treatment increased the
expression of KCNQ ion channels, with the greatest effect on the
subtype KCNQ4. KCNQ4 plays key roles in the auditory system.
NT-3 caused smaller, but statistically significant, increases in
KCNQ2 and 4 channels. Deleted in colorectal cancer (DCC) is
neuron-specific and is used as the reference gene. There was no
significant effect of neurotrophin treatment on DCC expression,
where GAPDH is the reference gene. ***pb0.001.cultured and treatedwith neurotrophins as described in the Cell
culture and neurotrophin treatment section. At the 7 day time
point, cells were fixed with 4% paraformaldehyde for 12 min,
permeabilized with 0.1% triton-X for 10 min, blocked in normal
donkey serum (NDS) for 1 h and incubated in a rabbit
anti-KCNQ4 antibody diluted 1:200 in 5% NDS overnight at 4 °C
(KCNQ4 antibody was a gift of Dr. Bechara Kachar, NIDCD). The
solution was subsequently exchanged for a mouse anti-TUJ1
primary antibody (Covance) diluted 1:250 in 5% NDS and
incubated overnight again at 4 °C. The antibody dilution was
empirically defined based on previous studies with these cells.
Samples were rinsed, incubated in secondary antibody for 2 h
(1:500 AlexaFluor 594 donkey anti-rabbit, 1:500 AlexaFluor 633
donkey anti-mouse), counterstained with Hoechst (20 μg/mL)
for 2 min, rinsed and coverslipped with ProLong Gold. Second-
ary antibodies, ProLong Gold and Hoechst were obtained from
Invitrogen. Samples were viewed on an Olympus FluoView
FV-500 confocal microscope. Five images were taken for each
condition, and levels of KCNQ4 protein expression were
quantified using ImageJ. Field locations for imaging were
determined a priori. The cell soma for every cell in each
image was selected and measured for an average gray value
within the selection. This is the sum of the gray values of all the
pixels in the selection divided by the number of pixels. Thus, the
gray value is corrected for the sample area and expressed in
“arbitrary units” (A.U.). Data were further analyzed according
to Neuron-specific class III β-tubulin (TUJ1) positivity to assess
whether KCNQ4 upregulation was preferential in neuronal
(TUJ1+) or non-neuronal (TUJ1−) populations.Statistics
Data are presented as means± standard error. Means were
compared with ANOVA followed by a Tukey post-hoc test.
For comparisons of KCNQ4 intensity in TUJ1+ and TUJ1−
populations, a mixed model was used to account for the
clustering in the data set by condition followed by a
Bonferonni post-hoc test. An SPSS software package (IBM)
was used for all statistical analysis. Significance was
determined at the pb0.05 level.Results
BDNF and NT-3 differentially affect passive electrical
properties
For these measurements, cells with a bipolar neuronal
morphology were selected. BDNF produced a significant
reduction in resting membrane potential (RMP) in comparison
to control and NT-3 treated conditions (Table 1). There was a
lesser shift in RMP with NT-3 treatment that was not
statistically significant. Changes in passive properties imply
neuronal maturation after BDNF exposure (Table 1) (Magnuson
et al., 1995). BDNF significantly reduced the input resistance
(Rin) and increased the membrane capacitance (Cm), indicat-
ing acquisition of ion channels and increased cell size and/or
arborization (pb0.05, ANOVA). NT-3 produced trends in these
passive properties in a similar direction, but the effects were
not statistically significant.
Figure 2 BDNF and NT-3 treatment increased KCNQ4 expression at the protein level. (A) Representative images indicate that BDNF
produces bright somatic labeling in cells. Scale=50 μm. (B) Magnified images demonstrate the diffuse somatic labeling of KCNQ4
(red, arrows) in neuronal cells (TUJ1+, yellow). Labeling in neurites was not observed. GFP is not shown in this panel to improve
visualization of KCNQ4 expression. Scale=10 μm. (C) Quantitative analysis shows a significant increase in KCNQ4 staining intensity
following BDNF and NT-3 treatment. (D) KCNQ4 labeling was most intense in TUJ1+ neuronal cells. Units in (C) and (D) are “arbitrary
units” (A.U.) indicating the average gray value of individual pixels within the sampled area. ***pb0.001.
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comparison to other subtypes
The reduction in RMP indicated an effect of neurotrophin
exposure on ion channel expression. BDNF significantly and
specifically increased expression of the KCNQ4 potassium
channel subtype in comparison to control and NT-3 treated
cells (9-fold for BDNF versus 1.6-fold for NT-3, pb0.001,
ANOVA) (Fig. 2). KCNQ4 is a Kv7 channel which plays a
preeminent role in the auditory system and is implicated in
progressive high‐frequency hearing loss (Beisel et al., 2000;
Kharkovets et al., 2000; Kubisch et al., 1999; Oliver et al.,
2003). The other neuronally expressed KCNQ subtypes probed
(KCNQ2, 3, and 5) were relatively unaffected by neurotrophin
treatment, with minor but statistically significant increases in
KCNQ2 and KCNQ5 expression (Fig. 2). These increases were
less than 3-fold in magnitude. Deleted in colorectal cancer
(DCC) is used as the reference gene. DCC is preferentially
expressed in neuronswithin the heterogeneous cell population(Hill et al., 2012). There was no significant effect of
neurotrophin treatment on DCC expression (GAPDH reference,
not shown).BDNF increases neuronal KCNQ4 expression at the
protein level
We performed quantitative immunohistochemistry to verify
that the transcriptional changes in KCNQ4 translated to
increases at the protein level. Both BDNF and NT-3 increased
KCNQ4 expression in cells following Neurog1 induction, with
BDNF producing the most pronounced effect (Fig. 2A–C).
Neurotrophin effects on KCNQ4 expression at the protein
level showed similar trends to effects on transcript levels,
although NT-3 produced a relatively more robust effect at
the protein level in comparison to the protein transcript
level (Figs. 1 and 2A–C). KCNQ4 expression was diffuse in the
soma, without preferential localization to a particular
33BDNF increases KCNQ4 expression in neurons derived from embryonic stem cellssomatic compartment (Fig. 2B). Expression was not observed
in neurites.
As stem cells may give rise to a diverse population of
cells, we further analyzed the KCNQ4 expression according
to neuronal (TUJ1+) and non-neuronal (TUJ1−) cell
populations. Overall TUJ1% varied according to treatment
condition, with control, NT-3, and BDNF-treated cells
yielding 1.7%, 10.5%, and 59.4% TUJ-1 positivity respective-
ly. KCNQ4 expression was significantly increased in TUJ1+
cells in comparison to non-neuronal cells (Fig. 2D, pb0.001,
mixed model ANOVA). BDNF-treated cells exhibited the most
intense KCNQ4 expression, followed by NT-3 and control
cells (Fig. 2C). Very rarely, cells expressed a neuronal
nuclear label typically associated with mature neurons
(NeuN) in BDNF and NT-3 treated cells (b2% of cells, not
shown). NeuN staining was not observed in control cells.Discussion
Sensory neurons, including those in the spiral ganglia, typically
display a variety of electrophysiological features, enabling the
encoding of a range of stimuli. In the auditory nerve, neurons
are tonotopically organized,where position-dependent changes
in frequency encoding accompany differences in potassium
channel distribution and firing patterns (Adamson et al., 2002a,
2002b; Lv et al., 2010). In this study, combining an induced
genetic cue with neurotrophin exposure yielded stem cell-
derived neurons with distinct passive electrical properties and
voltage-gated potassium channel expression.
A previous electrophysiological characterization of these
Neurog1-induced neurons revealed acquisition of voltage-gated
potassium, calcium, and sodium currents as early as 4 days
following dox exposure. However, the non-inactivating and
inactivating potassium conductances isolated activated at
voltages positive to −40 mV, and no evidence of low-
voltage-activated potassium channels was found (Tong, et al.,
2010). An early recording from a BDNF-treated cell, however,
demonstrated a linopirdine-sensitive potassium current which
activated at −60 mV (Supplementary Fig. 1); these character-
istics are consistent with KCNQ currents (Wladyka and Kunze,
2006). Based on this observation and the reduction in resting
potential, we hypothesized that BDNF exposuremay be coupled
to an upregulation of KCNQ channels, and our qPCR data
demonstrated a pronounced and specific increase in transcrip-
tion of the KCNQ4 subtype.
While the conductances underlying setting the neuronal
RMP are incompletely understood, the two-pore domain
(KCNK) and Kv7 (KCNQ) potassium channel families are key
contributors to setting RMP (Bean, 2007; Goldstein et al.,
2001). Of the KCNQ channels, KCNQ4 channels have the most
restricted expression, being predominantly localized to the
auditory pathway where they play key roles in controlling
resting potentials and calcium influx (Beisel et al., 2000;
Kharkovets et al., 2000; Kubisch et al., 1999; Oliver et al.,
2003). Notably, mutations in the KCNQ4 gene cause a
nonsyndromic form of progressive high‐frequency hearing
(Kubisch et al., 1999). The novel observation of a BDNF-
selective increase in KCNQ4 in the present study suggests a
link between high concentrations of this neurotrophin in the
cochlear base with high expression levels of the KCNQ4
channel in the same region. Following the period ofembryogenesis, in which BDNF expression progresses in an
apex-to-base fashion during development, a high-to-low,
base-to-apex BDNF expression pattern is established (Farinas
et al., 2001; Ruttiger et al., 2007). In the adult, both BDNF and
KCNQ4 are expressed in a base-to-apex gradient in spiral
ganglion neurons, although the normally high levels of BDNF
found in the high‐frequency-encoding cochlear base are lost
with age (Beisel et al., 2000; Ruttiger et al., 2007). It is pos-
sible that loss of BDNF with age could produce related effects
on KCNQ4 expression, potentially contributing to certain
forms of high‐frequency and age-related hearing loss. As
KCNQ4 expression is the most restricted of the neuronal KCNQ
channels, being found in the inner ear and discrete brainstem
nuclei, our results also raise the possibility of a connection
between BDNF and KCNQ4 expression in non-auditory path-
ways (Hansen et al., 2008; Kharkovets et al., 2000).
The observation of context-dependent expression of the
potassium channels known to contribute to RMP may be
interconnected to neuronal differentiation, maturation and
viability. The resting potential of neuronal progenitors is
typically depolarized (N−40 mV) and gradually decreases
with maturation (~−50 to −70 mV) (Magnuson et al., 1995;
Nakanishi and Okazawa, 2006). Decreased resting potential in
the present data may be symptomatic of BDNF-generated
cellular maturation. Effects on TUJ1 positivity, passive proper-
ties and protein expression in the present data would seem to
support this idea. However, it is striking that the KCNQ subtypes
(2,3,5)which are expressed in neurons throughout the brain and
peripheral nervous system were relatively unaffected by BDNF
treatment (Dalby-Brown et al., 2006). Additionally, while
Neurog1 is required for the development of small diameter
sensory neurons of the dorsal root ganglion (DRG), which
predominantly express KCNQ2/3, application of nerve growth
factor produced no effect on KCNQ expression in the neurons in
the present study (data not shown) (Ma et al., 1999; Passmore
et al., 2003). This specific upregulation of the KCNQ4 subtype
indicates a fine level of transcriptional control, where BDNF
activation of cell type-specific receptors may interact with a
Neurog1-initiated program in complex ways.
BDNF effects on resting potential have potential implications
for neuronal viability and mechanisms of neurodegeneration in
neurons of the Neurog1 lineage. Recent reports reveal evidence
of KCNQ4 expression in a minority of DRG neurons (~10%) and
BDNF-dependent survival of these cells in the early postnatal
period (Heidenreich et al., 2012; Valdes-Sanchez et al., 2010).
In mature SGNs, depolarized resting potentials can activate
voltage-gated calcium channels, resulting in elevated intracel-
lular calcium concentrations and the activation of downstream
cell death pathways (Lv et al., 2010). If future work reveals that
KCNQ4 is expressed in a BDNF-dependent manner in mature
cells as well as in developing neurons, new pathways for BDNF
rescue of sensory neuron degeneration may emerge.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2012.08.005.
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